SHATTUCK LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.78 USD | -2.88% |
|
+1.79% | +51.19% |
| 05-02 | Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-04 | Shattuck Labs, Inc. Announces Board Appointments | CI |
Chart calendar Shattuck Labs, Inc.
8b9c4ccedfa32ca36a5f6a85de6fa2e._iZkcvFoq_mwnUB35DwdT5lgPhqXHruK3DetLZ2Y7D8.mHJVSqtF_qD36zYclU5ZPv4JBlPbQc7NvW_nbKzZrVKGUDY7iVzfz4PqDQ~4068c5481a4c2626c487405204ed733a
Upcoming events on Shattuck Labs, Inc.
Past events on Shattuck Labs, Inc.
| 02/05/2024 12:05 | Q1 2024 Earnings Release |
| 17/04/2024 17:00 | Citi Biotech C-Suite Conference |
| 10/04/2024 00:05 | American Association for Cancer Research Meeting - Abstract Number: 6584 |
| 08/04/2024 18:30 | Needham Healthcare Conference |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 15:30 | TD Cowen Health Care Conference |
| 29/02/2024 21:05 | Q4 2023 Earnings Release |
| 11/01/2024 20:00 | J.P. Morgan Healthcare Conference |
| 13/12/2023 13:00 | Business Update Call |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract (#4278) |
| 29/11/2023 14:10 | Evercore ISI HealthCONx Conference |
| 09/11/2023 13:00 | Q3 2023 Earnings Call |
| 09/11/2023 11:00 | Q3 2023 Earnings Release |
| 10/08/2023 21:00 | Q2 2023 Earnings Release |
| 05/06/2023 19:15 | American Society of Clinical Oncology Conference - Poster No - #239 |
| 23/05/2023 16:00 | Annual General Meeting |
| 09/05/2023 21:00 | Q1 2023 Earnings Release |
| 19/04/2023 19:15 | Needham Healthcare Conference - Fireside Chat |
| 17/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract No 1815 |
| 13/04/2023 | American Association for Cancer Research Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,89 | 9,93 10,00 -0.62% | 30,0 2,26 1226.43% | 0,65 0,25 163.25% | 1,66 1,14 45.71% | 2,10 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -43,9 -73,0 39.88% | -100 -102 1.33% | -87,9 -95,4 7.81% | -90,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -36,9 -40,3 8.38% | -45,3 -73,6 38.46% | -103 -104 0.27% | -92,0 -99,2 7.26% | -87,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -45,0 -73,0 38.39% | -102 -103 0.81% | -87,3 -95,2 8.26% | -82,9 |
|
Net income Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -45,0 -73,0 38.39% | -102 -103 0.96% | -87,3 -94,9 8.05% | -82,9 |
|
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -1,07 -1,73 38.15% | -2,41 -2,42 0.41% | -2,05 -2,20 6.71% | -1,57 |
| Announcement Date | 18/09/20 | 15/03/21 | 15/03/22 | 23/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,38 - | 0,05 0,00 - | 0,21 0,00 - | 0,39 0,02 1633.33% | 0,06 0,09 -32.94% | 0,20 0,09 122.22% | 0,69 0,17 294.25% | 0,71 0,20 253.47% | 1,12 0,18 509.96% | 0,32 | 0,36 | 0,38 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -23,7 -21,9 -8.19% | -26,5 -24,6 -7.82% | -24,3 -28,7 15.35% | -25,3 -27,6 8.44% | -20,6 -27,4 24.65% | -20,3 -22,6 10.09% | -27,6 -23,5 -17.35% | -18,0 -23,9 24.78% | -19,1 -19,9 4.17% | -21,8 | -23,2 | -25,6 | ||
|
EBIT Million USD | Released Forecast Spread | -24,2 -21,9 -10.35% | -27,7 -25,3 -9.46% | -25,2 -28,5 11.32% | -26,3 -27,0 2.82% | -21,7 -25,8 15.88% | -22,7 -21,9 -3.71% | -28,6 -22,0 -30.14% | -19,0 -26,7 29.05% | -20,0 -21,0 4.39% | -21,3 | -22,3 | -23,2 | -21,0 | -21,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -24,6 0.29% | -27,4 -25,2 -8.51% | -24,6 -28,4 13.24% | -25,4 -27,0 5.72% | -20,7 -26,0 20.39% | -21,3 -22,1 3.31% | -27,5 -21,7 -26.67% | -17,7 -25,6 30.99% | -18,5 -21,1 12.3% | -20,5 | -21,5 | -22,4 | -20,0 | -20,0 |
|
Net income Million USD | Released Forecast Spread | -24,5 -24,6 0.29% | -27,4 -25,2 -8.51% | -24,6 -28,4 13.24% | -25,4 -27,0 5.72% | -20,7 -26,0 20.39% | -21,3 -22,1 3.31% | -27,5 -21,7 -26.67% | -17,7 -25,6 30.99% | -18,5 -21,1 12.3% | -20,5 | -21,5 | -22,4 | -20,0 | -20,0 |
|
EPS USD | Released Forecast Spread | -0,58 -0,58 0% | -0,65 -0,59 -9.55% | -0,58 -0,67 13.43% | -0,60 -0,63 5.14% | -0,49 -0,63 21.6% | -0,50 -0,52 2.91% | -0,65 -0,51 -26.95% | -0,41 -0,57 27.43% | -0,37 -0,46 19.13% | -0,41 | -0,39 | -0,39 | -0,39 | -0,39 |
| Announcement Date | 12/05/22 | 11/08/22 | 08/11/22 | 23/02/23 | 09/05/23 | 10/08/23 | 09/11/23 | 29/02/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for Shattuck Labs, Inc.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STTK Stock
- Calendar Shattuck Labs, Inc.
